The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 14, 2023

Filed:

Mar. 31, 2022
Applicant:

Beta Bionics, Inc., Irvine, CA (US);

Inventors:

Michael J. Rosinko, Las Vegas, NV (US);

Firas H. El-Khatib, Allston, MA (US);

John R. Costik, Livonia, NY (US);

Assignee:

Beta Bionics, Inc., Irvine, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61M 5/172 (2006.01); G16H 20/17 (2018.01); A61B 5/145 (2006.01); G16H 40/67 (2018.01); G16H 40/63 (2018.01); A61M 5/142 (2006.01); G16H 40/40 (2018.01); G06Q 30/0601 (2023.01); G16H 40/20 (2018.01); G05B 23/02 (2006.01); G06Q 20/40 (2012.01); G16H 15/00 (2018.01); G16H 50/70 (2018.01); A61M 5/14 (2006.01);
U.S. Cl.
CPC ...
G16H 20/17 (2018.01); A61B 5/14532 (2013.01); A61M 5/14244 (2013.01); A61M 5/14248 (2013.01); A61M 5/172 (2013.01); A61M 5/1723 (2013.01); G05B 23/0283 (2013.01); G06Q 20/401 (2013.01); G06Q 30/0631 (2013.01); G06Q 30/0633 (2013.01); G16H 15/00 (2018.01); G16H 40/20 (2018.01); G16H 40/40 (2018.01); G16H 40/63 (2018.01); G16H 40/67 (2018.01); G16H 50/70 (2018.01); A61M 2005/1402 (2013.01); A61M 2005/14208 (2013.01); A61M 2205/18 (2013.01); A61M 2205/33 (2013.01); A61M 2205/3553 (2013.01); A61M 2205/3569 (2013.01); A61M 2205/3576 (2013.01); A61M 2205/3584 (2013.01); A61M 2205/502 (2013.01); A61M 2205/505 (2013.01); A61M 2205/52 (2013.01); A61M 2205/609 (2013.01); A61M 2205/80 (2013.01); A61M 2209/088 (2013.01); A61M 2230/201 (2013.01);
Abstract

Ambulatory medical devices that provide therapy to a subject, such as blood glucose control, are disclosed. Disclosed systems and devices can transmit a request to modify blood glucose control therapy delivered to a subject. The request can be transmitted via a voice-activated control system, the ambulatory medicament pump can include a medicament reservoir, a pump controller, a wireless data interface, and/or other elements. The device can receive an indication that the request to modify therapy is approved and, in response to the indication that the request to modify the blood glucose control therapy is approved, instruct the pump controller to modify the blood glucose control therapy delivered to the subject.


Find Patent Forward Citations

Loading…